Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis
Status:
Not yet recruiting
Trial end date:
2023-08-30
Target enrollment:
Participant gender:
Summary
This clinical trial is for patients who have been diagnosed with Kellgren-Lawrence (K&L)
Grade 2 or 3 knee osteoarthritis on radiographic examination. Only subjects who voluntarily
agree to participate by filling out the written Informed Consent document will undergo
screening for subject selection (inclusion/exclusion) criteria, at which time the severity of
OA in each knee will be used to determined which knee will be treated (index knee - i.e., the
more severely affected knee), and enroll in this study.